ENBREL® (etanercept) | Official Patient Site
ENBREL is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis. ENBREL is indicated for chronic moderate to severe plaque psoriasis (PsO) in children 4 years of age or older and adults who may benefit from taking injections or pills (systemic therapy) or phototherapy (ultraviolet light).
Dosing Instructions for Enbrel® (etanercept) - enbrelpro.com
ENBREL is indicated for the treatment of patients 4 years or older with chronic moderate to severe plaque psoriasis (PsO) who are candidates for systemic therapy or phototherapy. ENBREL is indicated for the treatment of active juvenile psoriatic …
Treating Psoriasis and Psoriatic Arthritis with Enbrel
The drug Enbrel (also known by its generic name etanercept) is a TNF-alpha inhibitor that was approved for people with psoriatic arthritis in January 2002 and for moderate-to-severe psoriasis in April 2004. In November 2016, the psoriasis indication was extended to include pediatric patients ages 4 years and older.
Enbrel Injections: Uses, Dosage & Side Effects - Drugs.com
2024年7月25日 · Enbrel is also used to treat plaque psoriasis in adults and children who are at least 4 years old. Enbrel is sometimes used with another medicine called methotrexate when treating rheumatoid arthritis and psoriatic arthritis. Warnings. Using Enbrel may increase your risk of developing certain types of cancer, including a rare type of lymphoma.